1. Home
  2. CX vs VTRS Comparison

CX vs VTRS Comparison

Compare CX & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemex S.A.B. de C.V. Sponsored ADR

CX

Cemex S.A.B. de C.V. Sponsored ADR

HOLD

Current Price

$12.44

Market Cap

17.3B

Sector

Industrials

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$15.95

Market Cap

17.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CX
VTRS
Founded
1906
1961
Country
Mexico
United States
Employees
39462
30000
Industry
Building Materials
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3B
17.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CX
VTRS
Price
$12.44
$15.95
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$12.21
$13.50
AVG Volume (30 Days)
4.2M
10.4M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
0.74%
3.21%
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$8.28
$4.41
Revenue Next Year
$4.34
$1.96
P/E Ratio
$19.03
$106.10
Revenue Growth
N/A
N/A
52 Week Low
$6.67
$8.63
52 Week High
$13.67
$17.53

Technical Indicators

Market Signals
Indicator
CX
VTRS
Relative Strength Index (RSI) 43.93 50.68
Support Level $12.19 $12.90
Resistance Level $12.70 $16.38
Average True Range (ATR) 0.34 0.34
MACD -0.07 -0.16
Stochastic Oscillator 15.29 34.13

Price Performance

Historical Comparison
CX
VTRS

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: